HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 23.367

Change

-0.02 (-0.07)%

Market Cap

USD 0.03B

Volume

7.94K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.26 (+0.56%)

USD 63.50B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+5.10 (+0.91%)

USD 12.35B
WRD:PA HSBC ETFs Public Limited Compa..

+0.38 (+1.07%)

USD 10.45B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.77 (+1.17%)

USD 8.60B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.75 (+0.57%)

USD 8.46B
WLD:PA Lyxor UCITS MSCI World D-EUR

+3.90 (+1.10%)

USD 7.00B
HHH:PA HSBC ETFs Public Limited Compa..

+0.58 (+1.03%)

USD 6.90B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.20 (+1.09%)

USD 6.43B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+3.78 (+0.95%)

USD 5.51B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.55 (+0.96%)

USD 4.88B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.03% 65% D 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.03% 65% D 72% C
Trailing 12 Months  
Capital Gain 25.53% 68% D+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.53% 68% D+ 75% C
Trailing 5 Years  
Capital Gain 45.80% 66% D+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.80% 66% D+ 75% C
Average Annual (5 Year Horizon)  
Capital Gain 10.84% 64% D 65% D
Dividend Return N/A 90% A- 66% D+
Total Return N/A 31% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) N/A 72% C 90% A-
Risk Adjusted Return N/A 87% B+ 41% F
Market Capitalization 0.03B 10% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.